Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05540964 |
|---|---|
| Brief Title: | An Antiretroviral Treatment Interruption (ATI) Study to Evaluate the Impact of Genetically Modified Autologous Cells (AGT103-T) to Suppress Human Immunodeficiency Virus Replication in the Absence of Antiretroviral Therapy |
| First Submitted : | September 8, 2022 |
| First Submitted that Met QC Criteria : | September 12, 2022 |
| First Posted : | September 15, 2022 |
| Last Update Submitted that Met QC Criteria : | November 30, 2022 |
| Last Update Posted : | December 2, 2022 |